Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Beacon for Rare Diseases

  1. Events
  2. Organisers
  3. Beacon for Rare Diseases
Events from this organiser
Today

The Cambridge Rare Disease Showcase

This annual event serves as a celebration of the innovative work and compelling narratives emerging from the rare disease community. It is designed to bring [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top